Inventionis a method for suppressing angiogenesis via targets outside VEGFA, which iscommonly a target of most interventions. While this method still targets VEGFA,inventor discovered it also suppressed angiogenesis by activating FcγRI.
[Detail]
Steven M. Nowick, Ph.D.
[Detail]
Performance:Speed: operation at human-like speeds without performance degradation; tendon excursions and tensions can each be sampled at 200 HzStrength: 25 lbf dynamic operating rangePrecision Control: enabled by cable pre-tensioning mechanism (prevents tendon slack) and integrated load cell (measur.....
[Detail]
Ehrt S, et al (2005) Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.http://nar.oxfordjournals.org/cgi/content/full/33/2/e21Gandotra, S et al (2007) In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to per.....
[Detail]
| |< <- | [3004] [3005] [3006] [3007] [3008] [3009] [3010] [3011] [3012] [3013] [3014] | -> >| |

